Adiuvo Investment SA
Adiuvo Investments S.A. is a venture capital firm specializing in incubation, seed, startup, early venture, and growth capital investments. The firm primarily invests in projects in the segment of medical devices, biomedical, life-science, digital health, technologies and nutraceuticals including functional food. It seeks to invest in Poland. It prefers to hold its investments from three up to fi… Read more
Adiuvo Investment SA (ADV) - Net Assets
Latest net assets as of September 2025: zł-36.56 Million PLN
Based on the latest financial reports, Adiuvo Investment SA (ADV) has net assets worth zł-36.56 Million PLN as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł8.74 Million) and total liabilities (zł45.31 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł-36.56 Million |
| % of Total Assets | -418.22% |
| Annual Growth Rate | N/A |
| 5-Year Change | -219.8% |
| 10-Year Change | -157.09% |
| Growth Volatility | 335.4 |
Adiuvo Investment SA - Net Assets Trend (2013–2024)
This chart illustrates how Adiuvo Investment SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Adiuvo Investment SA (2013–2024)
The table below shows the annual net assets of Adiuvo Investment SA from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | zł-34.74 Million | +22.33% |
| 2023-12-31 | zł-44.73 Million | +5.64% |
| 2022-12-31 | zł-47.40 Million | -749.11% |
| 2021-12-31 | zł7.30 Million | -74.82% |
| 2020-12-31 | zł29.00 Million | -37.93% |
| 2019-12-31 | zł46.72 Million | -13.48% |
| 2018-12-31 | zł53.99 Million | +4.73% |
| 2017-12-31 | zł51.55 Million | -32.95% |
| 2016-12-31 | zł76.89 Million | +26.35% |
| 2015-12-31 | zł60.86 Million | +84.41% |
| 2014-12-31 | zł33.00 Million | +661.09% |
| 2013-12-31 | zł4.34 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Adiuvo Investment SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17300100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | zł1.32 Million | % |
| Other Comprehensive Income | zł5.95 Million | % |
| Other Components | zł136.76 Million | % |
| Total Equity | zł-33.40 Million | 100.00% |
Adiuvo Investment SA Competitors by Market Cap
The table below lists competitors of Adiuvo Investment SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Astron Paper & Board Mill Limited
NSE:ASTRON
|
$686.47K |
|
EOH Holdings Limited
JSE:EOH
|
$686.74K |
|
Conduit Pharmaceuticals Inc.
NASDAQ:CDT
|
$688.08K |
|
Irisity AB
ST:IRIS
|
$688.20K |
|
ATTIJARIWAFA BANK
BC:ATTIJARIWAFA-BANK
|
$685.74K |
|
Dr. Foods Inc.
OTCQB:DRFS
|
$685.42K |
|
Brimstone Investment Corporation Limited
JSE:BRN
|
$684.28K |
|
Astra Energy Inc
OTCQB:ASRE
|
$683.50K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Adiuvo Investment SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -49,426,000 to -33,403,000, a change of 16,023,000.
- Net loss of 2,788,000 reduced equity.
- Other comprehensive income increased equity by 1.
- Other factors increased equity by 18,810,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł-2.79 Million | -8.35% |
| Other Comprehensive Income | zł1.00 | +0.0% |
| Other Changes | zł18.81 Million | +56.32% |
| Total Change | zł- | % |
Book Value vs Market Value Analysis
This analysis compares Adiuvo Investment SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | zł0.83 | zł0.58 | x |
| 2014-12-31 | zł3.10 | zł0.58 | x |
| 2015-12-31 | zł5.97 | zł0.58 | x |
| 2016-12-31 | zł6.00 | zł0.58 | x |
| 2017-12-31 | zł3.60 | zł0.58 | x |
| 2018-12-31 | zł3.54 | zł0.58 | x |
| 2019-12-31 | zł2.80 | zł0.58 | x |
| 2020-12-31 | zł1.65 | zł0.58 | x |
| 2021-12-31 | zł0.02 | zł0.58 | x |
| 2022-12-31 | zł-3.93 | zł0.58 | x |
| 2023-12-31 | zł-3.75 | zł0.58 | x |
| 2024-12-31 | zł-2.54 | zł0.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Adiuvo Investment SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -834.73%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-638.14%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -81.96% | 0.00% | 0.00x | 4.39x | zł-3.53 Million |
| 2014 | 9.22% | 4786.11% | 0.00x | 2.89x | zł-145.70K |
| 2015 | -37.71% | -456.29% | 0.05x | 1.81x | zł-22.73 Million |
| 2016 | -29.67% | -359.82% | 0.05x | 1.68x | zł-22.99 Million |
| 2017 | -143.46% | -912.22% | 0.09x | 1.83x | zł-56.23 Million |
| 2018 | -71.52% | -973.80% | 0.03x | 2.18x | zł-31.01 Million |
| 2019 | -48.53% | -968.05% | 0.02x | 2.14x | zł-20.76 Million |
| 2020 | -59.89% | -1381.00% | 0.01x | 3.27x | zł-15.18 Million |
| 2021 | -7194.19% | -1080.92% | 0.03x | 234.90x | zł-17.36 Million |
| 2022 | 0.00% | -33465.90% | 0.02x | 0.00x | zł-52.71 Million |
| 2023 | 0.00% | -1094.95% | 0.45x | 0.00x | zł-5.90 Million |
| 2024 | 0.00% | -834.73% | 0.56x | 0.00x | zł552.30K |
Industry Comparison
This section compares Adiuvo Investment SA's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $34,792,958
- Average return on equity (ROE) among peers: -150.53%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Adiuvo Investment SA (ADV) | zł-36.56 Million | -81.96% | N/A | $685.90K |
| Braster S.A. (BRA) | $650.00K | -601.08% | 36.39x | $2.89 Million |
| Genomtec S.A. (GMT) | $7.57 Million | -144.47% | 0.24x | $13.47 Million |
| Medinice S.A (ICE) | $8.23 Million | -27.31% | 0.42x | $51.38 Million |
| Medicalg (MDG) | $99.19 Million | 14.04% | 0.03x | $35.78 Million |
| Synektik S.A. (SNT) | $58.33 Million | 6.18% | 0.83x | $272.86 Million |